Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity

Results from a global survey of over 4,300 women across five continents presented at IMCAS 2026 reveal a knowledge gap on the impact of menopause on the skin, despite women experiencing around three skin changes during menopause1
Galderma will also host a symposium delving into the challenges and science behind menopause-related skin changes and aesthetic solutions at the congress
Galderma is committed to raising awareness of the impact of menopause on the skin, fostering meaningful dialogue between patients and healthcare professionals, and advancing science-backed solutions by incorporating menopausal status into all injectable aesthetics clinical trials

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) has unveiled findings from a global survey of peri- and post-menopausal women from nine countries exploring the impact of menopause on the skin at the International Master Course on Aging Science (IMCAS) 2026 World Congress in Paris, France, from January 29-31, 2026. The survey found that over 50% of women learned about the effects of menopause on the skin by going through it themselves, with most finding out about it in their 40s.2 However, over 30% would have liked to learn about this in their 30s and over 50% are at best neutral or dissatisfied with their knowledge on the topic.2

To address this knowledge gap, Galderma will leverage its expertise in dermatology to advance awareness, understanding, education, and treatment approaches for menopause-related skin changes. With around 85% of aesthetic patients being female, it is important to understand how these treatments can support women at all stages of life, especially during the complex time of the menopause.3 To help advance this understanding, Galderma has made the pioneering decision to now include menopausal status in its clinical trials to provide critical insights into how its injectable aesthetic treatments can best serve this patient population.

Menopausal women experience a decline in estrogen, which supports many aspects of skin health, with fluctuations starting in the peri-menopausal stage.4,5 Decreasing estrogen leads to an expedited decline in collagen and elastin, with a 30% reduction in collagen seen within the first five years post-menopause, causing the skin to lose firmness and be more prone to wrinkles.4-6 It also decreases the hyaluronic acid levels in the skin, which can result in dehydration, dryness, and itchiness.4

Often not very well-known and understood, the effects of menopause on the skin are frequently overlooked but can negatively impact wellbeing.2,7,8 Galderma’s survey found that women agreed or strongly agreed that menopause-related skin changes made them feel less attractive (60%), anxious (57%), less confident (55%), and want to socialize less (46%).1 Aesthetic treatments can help to address this by targeting the root causes and correcting these skin changes for an enhanced look, and as a result, can boost confidence and positive self-perception.4,5